Freeline Therapeutics' Series A - II Round

Freeline Therapeutics raised a round of funding on June 20, 2016. Investors include UCL Technology Fund.

Freeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of gene therapies for bleeding and other debilitating disorders.…

Articles about Freeline Therapeutics' Series A - II Round: